Key facts
- It has raised $290K; the latest was Seed Round ($290K) in Feb 2026.
- Notable investors include Scalewolf.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Nexus Dynamix
- ·The full record, as it builds
Funding rounds
No funding rounds for Nexus Dynamix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nexus Dynamix
Developer of a microgravity simulation platform designed for firms and researchers to replicate orbital conditions. The company offers drug discovery, longevity research, and defense testing using AI-driven multi-axis motion technology, enabling scientists to perform experiments for protein crystallization and tissue engineering.
- Sector
- Healthcare
- HQ
- Vilnius, Lithuania
- Founded
- 2024
- Employees
- 3
- Website
- nexusdynamix.com/
- Ownership
- Privately Held (backing)
Nexus Dynamix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nexus Dynamix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nexus Dynamix in its N-PORT filings yet. We sweep new filings monthly.